Publications by Kjell Nustad
141 publications found
Original articles
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors
Clin Biochem, 52, 73-79
DOI 10.1016/j.clinbiochem.2017.11.016, PubMed 29198759
HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank
Int J Gynecol Cancer, 25 (9), 1608-15
DOI 10.1097/IGC.0000000000000532, PubMed 26501436
Heterophilic antibody interference in immunometric assays
Best Pract Res Clin Endocrinol Metab, 27 (5), 647-61
DOI 10.1016/j.beem.2013.05.011, PubMed 24094636
Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
Tumour Biol, 33 (1), 141-8
DOI 10.1007/s13277-011-0256-4, PubMed 22105734
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
Clin Chem Lab Med, 49 (12), 2001-6
DOI 10.1515/CCLM.2011.702, PubMed 21899496
Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity
Blood, 118 (12), 3331-9
DOI 10.1182/blood-2011-03-341651, PubMed 21725051
Activation of EphA receptors on CD4+CD45RO+ memory cells stimulates migration
J Leukoc Biol, 87 (6), 1059-68
DOI 10.1189/jlb.0709497, PubMed 20160140
Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors
J Reprod Med, 55 (7-8), 285-95
PubMed 20795340
Exploring the complementary selectivity of immunocapture and MS detection for the differentiation between hCG isoforms in clinically relevant samples
J Proteome Res, 8 (11), 5241-52
DOI 10.1021/pr900580n, PubMed 19719329
Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the second TD-10 workshop
Tumour Biol, 30 (1), 26-36
DOI 10.1159/000199448, PubMed 19194112
Expression and epitope characterization of a recombinant CA 125 repeat: fourth report from the ISOBM TD-1 workshop
Tumour Biol, 30 (2), 51-60
DOI 10.1159/000209988, PubMed 19321947
Automated time-resolved immunofluorometric assay for progastrin-releasing peptide
Clin Chem, 54 (5), 919-22
DOI 10.1373/clinchem.2007.101436, PubMed 18443179
Progastrin-releasing peptide: stability in plasma/serum and upper reference limit
Tumour Biol, 29 (3), 204-10
DOI 10.1159/000148188, PubMed 18667845
Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study
Scand J Clin Lab Invest, 68 (8), 703-13
DOI 10.1080/00365510802126836, PubMed 18609108
Human heterophilic antibodies display specificity for murine IgG subclasses
Clin Biochem, 38 (5), 465-72
DOI 10.1016/j.clinbiochem.2005.02.008, PubMed 15820778
Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies
Clin Chem, 51 (5), 830-8
DOI 10.1373/clinchem.2004.046979, PubMed 15718486
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study
Br J Cancer, 91 (10), 1829-34
DOI 10.1038/sj.bjc.6602199, PubMed 15477862
Testing and validating a homogeneous immunometric assay for interference
Clin Chem Lab Med, 42 (2), 208-14
DOI 10.1515/CCLM.2004.038, PubMed 15061363
Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
Tumour Biol, 25 (1-2), 31-40
DOI 10.1159/000077721, PubMed 15192310
Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the TD-10 Workshop
Tumour Biol, 25 (1-2), 69-90
DOI 10.1159/000077726, PubMed 15192315
Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop
Tumour Biol, 23 (4), 249-62
DOI 10.1159/000067255, PubMed 12499780
Epitopes on CA 125 from cervical mucus and ascites fluid and characterization of six new antibodies. Third report from the ISOBM TD-1 workshop
Tumour Biol, 23 (5), 303-14
DOI 10.1159/000068570, PubMed 12595747
Immunometric assay interference: incidence and prevention
Clin Chem, 48 (4), 613-21
PubMed 11901059
MUC1 serum assays in breast cancer: tumor specificities and reference levels
Tumour Biol, 23 (6), 315-23
DOI 10.1159/000069790, PubMed 12677089
Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop
Tumour Biol, 23 (4), 228-48
DOI 10.1159/000067254, PubMed 12499779
Immunomagnetic DNA aptamer assay
Biotechniques, 30 (2), 290-2, 294-5
DOI 10.2144/01302st01, PubMed 11233597
CA 125: the end of the beginning
Tumour Biol, 22 (6), 345-7
DOI 10.1159/000050637, PubMed 11786728
Automated immunofluorometric assay for MUC1
Tumour Biol, 22 (3), 169-75
DOI 10.1159/000050612, PubMed 11275795
New immunoassays for MUC1 in breast cancer
Tumour Biol, 22 (4), 216-22
DOI 10.1159/000050619, PubMed 11399946
Elevated CA125 in breast cancer--A sign of advanced disease
Tumour Biol, 22 (4), 223-8
DOI 10.1159/000050620, PubMed 11399947
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass
Int J Cancer, 89 (6), 519-23
DOI 10.1002/1097-0215(20001120)89:6<519::AID-IJC9>3.0.CO;2-#, PubMed 11102897
Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients
Gynecol Oncol, 76 (3), 326-30
DOI 10.1006/gyno.1999.5699, PubMed 10684705
The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals
Obstet Gynecol, 93 (3), 448-52
DOI 10.1097/00006250-199903000-00028, PubMed 10074998
Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen
Tumour Biol, 20 Suppl 1, 52-69
DOI 10.1159/000056531, PubMed 10628410
Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997
Tumour Biol, 19 (5), 390-420
DOI 10.1159/000030032, PubMed 9701730
Carcinoma-associated MUC1 detected by immunoradiometric assays
Tumour Biol, 19 Suppl 1, 134-46
DOI 10.1159/000056515, PubMed 9422099
Summary report on the ISOBM TD-4 Workshop: Analysis of 56 monoclonal antibodies against the MUC1 mucin - San Diego, Calif., November 17-23, 1996
Tumor Biol., 19 1, 1-20
DOI 10.1159/000056500
CA 125--epitopes and molecular size
Int J Biol Markers, 13 (4), 196-9
DOI 10.1177/172460089801300404, PubMed 10228900
Specificity and affinity of 30 monoclonal antibodies against alpha-fetoprotein
Tumour Biol, 19 (4), 293-300
DOI 10.1159/000030021, PubMed 9679741
Evaluation of At-211-labelled monodisperse polymer particles in vivo: Comparison of different specific activities
J. Label. Compd. Radiopharm., 38 (9), 775-784
DOI 10.1002/(SICI)1099-1344(199609)38:9<775::AID-JLCR896>3.0.CO;2-U
Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses
Br J Obstet Gynaecol, 103 (8), 826-31
DOI 10.1111/j.1471-0528.1996.tb09882.x, PubMed 8760716
Biochemical and biomedical application of monodisperse polymer particles
Macromol. Symp., 101, 491-500
DOI 10.1002/masy.19961010155
Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer
Gynecol Oncol, 57 (2), 183-7
DOI 10.1006/gyno.1995.1122, PubMed 7729731
Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model
Gynecol Oncol, 57 (1), 9-15
DOI 10.1006/gyno.1995.1093, PubMed 7705707
[Preoperative identification of malignancy among women with a pelvic mass. Evaluation of a risk index based on ultrasound findings. CA 125 in serum and menopausal status]
Tidsskr Nor Laegeforen, 115 (7), 820-2
PubMed 7701488
A sequential binding assay with a working range extending beyond seven orders of magnitude
J Immunol Methods, 178 (1), 131-40
DOI 10.1016/0022-1759(94)00251-q, PubMed 7530267
Dual analyte assay based on particle types of different size measured by flow cytometry
J Immunol Methods, 178 (1), 141-51
DOI 10.1016/0022-1759(94)00252-r, PubMed 7530268
[Tumor marker analyses--valuable tools if used correctly]
Tidsskr Nor Laegeforen, 114 (28), 3317-20
PubMed 7809890
Demonstration and minimization of serum interference in flow cytometric two-site immunoassays
Clin Chem, 40 (3), 420-5
PubMed 7510591
AT-211-LABELING OF POLYMER PARTICLES FOR RADIOTHERAPY - SYNTHESIS, PURIFICATION AND STABILITY
J. Label. Compd. Radiopharm., 33 (10), 977-986
DOI 10.1002/jlcr.2580331012
Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis
Acta Oncol, 32 (3), 289-94
DOI 10.3109/02841869309093597, PubMed 8100712
Immunoconjugate stability in vivo measured by label release from 125I or 99mTc-antibody coated cells kept in intraperitoneal diffusion chambers in mice
Acta Oncol, 32 (7-8), 873-6
DOI 10.3109/02841869309096149, PubMed 8305239
EVIDENCE THAT HEPARIN COFACTOR-II PARTICIPATES IN THE CONTROL OF DISSEMINATED INTRAVASCULAR COAGULATION
INT CONGR SER, 1044, 125-128
Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model
Gynecol Oncol, 47 (3), 366-72
DOI 10.1016/0090-8258(92)90141-5, PubMed 1473751
Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice
Gynecol Oncol, 47 (3), 358-65
DOI 10.1016/0090-8258(92)90140-e, PubMed 1473750
In vivo measurement of the association constant of a radio-labelled monoclonal antibody in experimental immunotargeting
Br J Cancer, 66 (1), 74-8
DOI 10.1038/bjc.1992.219, PubMed 1637680
Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation
Thromb Res, 66 (5), 591-8
DOI 10.1016/0049-3848(92)90313-y, PubMed 1523613
B-cell hybridoma as intraperitoneal tumor model: correlation between tumor growth and monoclonal antibody production
Hybridoma, 11 (3), 323-31
DOI 10.1089/hyb.1992.11.323, PubMed 1500068
The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens
Eur J Nucl Med, 19 (6), 402-8
DOI 10.1007/BF00177366, PubMed 1618231
CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma
Tumour Biol, 13 (3), 168-74
DOI 10.1159/000217761, PubMed 1626181
Radio-immunotargeting in experimental animal models of intraperitoneal cancer
Acta Obstet Gynecol Scand Suppl, 155, 105-11
DOI 10.1111/j.1600-0412.1992.tb00015.x, PubMed 1502887
THE EFFECT OF THE BIODISTRIBUTION DIFFERENCES BETWEEN IGG, F(AB')2 AND FAB' ON THEIR IMMUNOTARGETING POTENTIAL FOR HUMAN TUMOR-CELLS IN IMMUNOCOMPETENT MICE
Antib. Immunoconjug. Radiopharm., 4 (4), 443-451
Tumour markers as seen from the clinical laboratory: physiological, biochemical, and analytical aspects
Scand J Clin Lab Invest Suppl, 206, 12-20
DOI 10.3109/00365519109107721, PubMed 1947756
A rapid and sensitive immunoassay for tumor necrosis factor using magnetic monodisperse polymer particles
J Immunol Methods, 134 (2), 253-9
DOI 10.1016/0022-1759(90)90387-b, PubMed 2254670
Species-dependent binding of serum albumins to the streptococcal receptor protein G
Eur J Biochem, 193 (1), 143-8
DOI 10.1111/j.1432-1033.1990.tb19315.x, PubMed 2171929
Radioimmunotargeting of human tumour cells in immunocompetent animals
Br J Cancer, 62 (4), 573-8
DOI 10.1038/bjc.1990.332, PubMed 2223574
Selection of monoclonal antibodies for use in an immunometric assay for carcinoembryonic antigen
J Immunol Methods, 127 (2), 171-8
DOI 10.1016/0022-1759(90)90066-5, PubMed 1690245
Immunometric assay by flow cytometry using mixtures of two particle types of different affinity
J Immunol Methods, 126 (2), 183-9
DOI 10.1016/0022-1759(90)90149-p, PubMed 2303729
Application of monosized, polymer particles in medicine
Scand J Clin Lab Invest Suppl, 202, 25-6
PubMed 2075438
Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation
Eur J Immunol, 20 (1), 201-6
DOI 10.1002/eji.1830200129, PubMed 1689662
APPLICATION OF MONOSIZED, POLYMER PARTICLES IN MEDICINE
Scand. J. Clin. Lab. Invest., 50 202, 25-26
Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles
Clin Chem, 35 (10), 2034-8
PubMed 2551540
Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies
Bone Marrow Transplant, 4 (5), 567-74
PubMed 2790334
Elimination of malignant clonogenic breast cancer cells from human bone marrow
Cancer Res, 49 (16), 4659-64
PubMed 2663144
In vivo evaluation of radiolabelled antibodies with antigen-coated polymer particles in diffusion chambers
J Immunol Methods, 109 (1), 1-7
DOI 10.1016/0022-1759(88)90435-8, PubMed 3356905
MONOSIZED MAGNETIC PARTICLES AND THEIR USE IN SELECTIVE CELL-SEPARATION
MAKROMOL CHEM-M SYMP, 17, 177-211
DOI 10.1002/masy.19880170113
High frequency of incomplete human chorionic gonadotropin in patients with testicular seminoma
J Urol, 139 (3), 542-4
DOI 10.1016/s0022-5347(17)42515-8, PubMed 2449547
Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use
Bone Marrow Transplant, 3 (1), 31-41
PubMed 3048468
IMMUNOMAGNETIC PURGING OF BETA-LYMPHOMA CELLS FROM BONE-MARROW
Bone Marrow Transplant., 3 1, 97
The diagnostic value of human chorionic gonadotrophin in patients with testicular seminoma
Br J Urol, 59 (6), 572-7
DOI 10.1111/j.1464-410x.1987.tb04880.x, PubMed 3690188
Excess antibody immunoassay for the measurement of tonin in rat tissues and plasma
J Immunol Methods, 98 (2), 257-65
DOI 10.1016/0022-1759(87)90013-5, PubMed 3033082
Placental alkaline phosphatase as a tumor marker in ovarian cancer
Obstet Gynecol, 69 (2), 228-32
PubMed 3808507
Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies
Cancer Res, 47 (3), 846-51
PubMed 3492268
ANTIGEN-BINDING PROPERTIES OF ANTIBODIES COATED ON MAGNETIC POLYMER BEADS
Bone Marrow Transplant., 2 2, 81-83
The interaction between cell-surface antigens and antibodies bound to monodisperse polymer particles in normal and malignant cells
Scand J Immunol, 24 (2), 179-87
DOI 10.1111/j.1365-3083.1986.tb02084.x, PubMed 3749814
Enzymatic activity of rat submandibular gland kallikrein released into blood
Am J Physiol, 249 (6 Pt 2), H1134-42
DOI 10.1152/ajpheart.1985.249.6.H1134, PubMed 3852648
ENZYMATIC-ACTIVITY OF RAT SUBMANDIBULAR-GLAND KALLIKREIN RELEASED INTO BLOOD
Am. J. Physiol., 249 (6), 1134-1142
PREPARATION AND APPLICATION OF MONODISPERSE POLYMER PARTICLES
J POLYM SCI POL SYM (72), 225-240
Highly sensitive solid-phase immunoenzymometric assay for placental and placental-like alkaline phosphatases with a monoclonal antibody and monodisperse polymer particles
Clin Chem, 31 (1), 54-9
PubMed 3880682
Excess antibody immunoassay for rat glandular kallikrein. Measurement of kallikrein complexed with inhibitors and in plasma
J Immunol Methods, 69 (2), 253-66
DOI 10.1016/0022-1759(84)90323-5, PubMed 6201559
MOUSE MONOCLONAL ANTI RABBIT IGG COUPLED TO MONODISPERSE POLYMER PARTICLES - COMPARISON WITH POLYCLONAL ANTIBODIES IN RADIOIMMUNOASSAY FOR THYROID-HORMONES
Dev. Biols, 57, 321-324
Hydrophilic monodisperse particles as solid-phase material in immunoassays: comparison of shell-and-core particles with compact particles
Eur Surg Res, 16 Suppl 2, 80-7
DOI 10.1159/000128626, PubMed 6562963
Evaluation of a new, sensitive radioimmunoassay for placental alkaline phosphatase in pre- and post-operative sera from the Danish testicular cancer material
Prog Clin Biol Res, 166, 337-48
PubMed 6504939
Mouse monoclonal anti rabbit IgG coupled to monodisperse polymer particles. Comparison with polyclonal antibodies in radioimmunoassay for thyroid hormones
Dev Biol Stand, 57, 321-4
PubMed 6526143
Excess antibody immunoassays for rat glandular kallikreins. Measurement of kallikrein from different organs in the presence of cross-reacting antigens
J Immunol Methods, 59 (3), 315-26
DOI 10.1016/0022-1759(83)90192-8, PubMed 6343492
Excess antibody immunoassay for rat glandular kallikrein. Monosized polymer particles as the preferred solid phase material
J Immunol Methods, 59 (2), 255-64
DOI 10.1016/0022-1759(83)90038-8, PubMed 6341471
Prostatic acid phosphatase, purification and iodination using Iodogen
Clin Chim Acta, 120 (1), 29-40
DOI 10.1016/0009-8981(82)90074-2, PubMed 7067137
Rapid purification of a prekallikrein from rat pancreas
Anal Biochem, 113 (2), 264-70
DOI 10.1016/0003-2697(81)90076-2, PubMed 6912775
Isolation of rat submandibula kallikreins by using immunoadsorption chromatography
Biochem J, 189 (1), 153-9
DOI 10.1042/bj1890153, PubMed 7006596
Intraglandular transport of 125I-glandular kallikrein in the rat submandibular salivary gland
Acta Physiol Scand, 109 (3), 315-23
DOI 10.1111/j.1748-1716.1980.tb06602.x, PubMed 6905637
Immunohistochemical localization of kallikrein in human pancreas and salivary glands
J Histochem Cytochem, 28 (6), 557-62
DOI 10.1177/28.6.6156199, PubMed 6156199
Origin of kallikrein in rat and human exocrine glands and kidney
Clin Sci (Lond), 57 Suppl 5, 239s-241s
DOI 10.1042/cs057239s, PubMed 396072
Localization of glandular kallikreins and secretion of kallikrein from the major salivary glands of the rat
Adv Exp Med Biol, 120A, 439-50
DOI 10.1007/978-1-4757-0926-1_40, PubMed 386736
Radioimmunoassay of rat submandibular gland kallikrein and the detection of immunoreactive antigen in blood
Adv Exp Med Biol, 120A, 225-34
DOI 10.1007/978-1-4757-0926-1_23, PubMed 495312
A biochemical and immunohistochemical study of kallikrein in normal and isoproterenol-stimulated rat salivary glands during postnatal development
Arch Oral Biol, 22 (8-9), 495-502
DOI 10.1016/0003-9969(77)90043-7, PubMed 341865
The location of prekallikrein in the rat pancreas [proceedings]
Biochem Soc Trans, 5 (5), 1402-4
DOI 10.1042/bst0051402, PubMed 411695
Rat submandibular gland kallikreins: purification and cellular localization
Br J Pharmacol, 56 (2), 155-67
DOI 10.1111/j.1476-5381.1976.tb07438.x, PubMed 1252668
Synthesis of kallikreins by rat kidney slices
Br J Pharmacol, 53 (2), 229-34
DOI 10.1111/j.1476-5381.1975.tb07353.x, PubMed 1148483
Cellular localization of kallikreins in rat submandibular and sublingual salivary glands: immunofluorescence tracing related to histological characteristics
Acta Histochem, 54 (2), 183-92
PubMed 56116
CELLULAR LOCALIZATION OF KALLIKREINS IN RAT SUBMANDIBULAR AND SUBLINGUAL SALIVARY-GLANDS - IMMUNOFLUORESCENCE TRACING RELATED TO HISTOLOGICAL CHARACTERISTICS
Acta Histochem., 54 (2), 183-&
Purification of rat urinary kallikreins and their specific antibody
Biochemistry, 13 (11), 2312-9
DOI 10.1021/bi00708a012, PubMed 4208777
Kininogenase activity in the stimulated submandibular salivary gland in cats
Acta Physiol Scand, 85 (4), 438-45
DOI 10.1111/j.1748-1716.1972.tb05277.x, PubMed 5074159
[The kinins and the inflammatory reaction]
Tidsskr Nor Laegeforen, 92 (11), 765-6
PubMed 5028895
Subcellular localization of renin and kininogenase in the rat kidney
Br J Pharmacol, 40 (2), 326-33
DOI 10.1111/j.1476-5381.1970.tb09925.x, PubMed 4321758
Localization of kininogenase in the rat kidney
Br J Pharmacol, 39 (1), 87-98
DOI 10.1111/j.1476-5381.1970.tb09558.x, PubMed 4315991
The relationship between kidney and urinary kininogenase
Br J Pharmacol, 39 (1), 73-86
DOI 10.1111/j.1476-5381.1970.tb09557.x, PubMed 5420147
Observations on the kininogenase activity of rat kidney and urine
Scand J Clin Lab Invest Suppl, 107, 97-8
PubMed 5375732
The influence of major surgery on kinin-forming, kinin-destroying and alkaline phosphatase activities in urine
Scand J Clin Lab Invest Suppl, 107, 163-7
PubMed 5385119
Kininogenase activity in the stimulated submandibular salivary gland in cat
Scand J Clin Lab Invest Suppl, 107, 101-2
PubMed 5375718
Kinin-forming and destroying activities of cell homogenates
J Physiol, 179 (3), 479-88
DOI 10.1113/jphysiol.1965.sp007674, PubMed 5858625
KININ-FORMING AND DESTROYING ACTIVITIES OF SALIVA
Br J Pharmacol Chemother, 23 (3), 440-4
DOI 10.1111/j.1476-5381.1964.tb01600.x, PubMed 14256804
KINIRASE ACTIVITY OF HUMAN SALIVA
Nature, 201, 1226-7
DOI 10.1038/2011226a0, PubMed 14151380
A STABLE SUBSTRATE FOR THE ASSAY OF PLASMA KININ-FORMING ENZYMES
Br J Pharmacol Chemother, 21 (3), 500-8
DOI 10.1111/j.1476-5381.1963.tb02018.x, PubMed 14110750
Review articles
Monosized, magnetic polymer particles: their use in separation of cells and subcellular components, and in the study of lymphocyte function in vitro
J Mol Recognit, 1 (1), 9-18
DOI 10.1002/jmr.300010104, PubMed 3078840
Glandular kallikreins
Gen Pharmacol, 9 (1), 1-9
DOI 10.1016/0306-3623(78)90049-6, PubMed 346434
Other articles
A man with abdominal pain: enough evidence for surgery?
Clin Chem, 58 (8), 1187-90
DOI 10.1373/clinchem.2011.167015, PubMed 22843812
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera (vol 49, pg 2001, 2011)
Clin. Chem. Lab. Med., 50 (2), 409
DOI 10.1515/cclm-2012-0038
The war on heterophilic antibody interference
Clin Chem, 51 (1), 9-11
DOI 10.1373/clinchem.2004.042994, PubMed 15613705
Tumor marker workshops
Tumour Biol, 24 (4), 165-71
DOI 10.1159/000074423, PubMed 14654709
Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop
Tumour Biol, 19 (2), 132-52
DOI 10.1159/000029984, PubMed 9486565
Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine
Tumour Biol, 17 (4), 196-219
DOI 10.1159/000217982, PubMed 8685601
Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop
Tumour Biol, 17 (6), 325-31
PubMed 8938947
Homogeneous immunofluorometric assays of alpha-fetoprotein with macroporous, monosized particles and flow cytometry
Clin Chem, 39 (10), 2174-81
PubMed 7691444
CLINICAL UTILITY OF TUMOR-MARKERS
Scand. J. Clin. Lab. Invest., 47 (3), 301-302
Effects of different tissue processing methods on the immunohistochemical localization of kallikrein in the pancreas
J Histochem Cytochem, 29 (8), 985-8
DOI 10.1177/29.8.7024403, PubMed 7024403
The immunological similarity of rat glandular kallikreins
Biochem J, 167 (3), 835-8
DOI 10.1042/bj1670835, PubMed 414745
Cellular origin of urinary kallikreins
J Histochem Cytochem, 24 (9), 1037-9
DOI 10.1177/24.9.965714, PubMed 965714
Books
Demonstration and minimization of serum interference in flow cytometric two-site immunoassays
American Association of Clinical Chemistry, [Winston-Salem, N.C.], S. 420-425
BIBSYS 941140954
Clinical evaluation of a flow cytometric particle-based immunometric assay for AFP in serum
[Wiley-Liss], [New York], Bl. 74.
BIBSYS 931704650
Homogeneous immunofluorometric assays of α-fetoprotein with macroporous monosized particles and flow cytometry
American Association of Clinical Chemistry, [Winston-Salem, N.C.], S. 2174-2181
BIBSYS 941140873
The relationship between urinary and kidney kallikreins in the rat
Oslo, 1 b. (Flere pag.)
BIBSYS 000871605